Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2003 Mar 15;111(6):925. doi: 10.1172/JCI200316336C

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

Jens Mogensen 1, Toru Kubo 1,2, Mauricio Duque 3, William Uribe 3, Anthony Shaw 1, Ross Murphy 1, Juan R Gimeno 1, Perry Elliott 1, William J McKenna 1
PMCID: PMC153780

Original citation: J. Clin. Invest. 111:209–216 (2003). doi:10.1172/JCI200316336.

Citation for this corrigendum: J. Clin. Invest. 111:925 (2003). doi:10.1172/JCI200316336C.

The authors wish to correct errors that appeared in the Methods section and throughout the paper. The correct sentences are below. The authors regret the errors.

Mutation analysis of TNNI3 by direct sequencing identified a 87A→G nucleotide substitution of exon 8 resulting in an Asp190Gly amino acid substitution that segregated with the disease in the family (maximal two-point lode score: 4.8).

Direct sequencing of TNNI3 identified a 93G→A nucleotide substitution of exon 8, which resulted in an Arg192His amino acid substitution.


Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES